Serum concentrations of insulin, insulin-like growth factor-I, and insulin-like growth factor binding proteins are different between white and African American girls

Journal of Pediatrics

Volumn 135, Issue 3, 1999, Pages 296-300

  Wong, William W ^a,b   Copeland, Kenneth C ^a,b   Hergenroeder, Albert C ^a,b   Hill, Rebecca B ^a,b   Stuff, Janice E ^a,b   Ellis, Kenneth J ^a,b  

^a CHILDREN S NUTRITION RESEARCH CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADOLESCENCE; ADOLESCENT; ARTICLE; BLOOD SAMPLING; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RACE DIFFERENCE; SCHOOL CHILD; SEXUAL MATURATION;

EID: 0033498226     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70123-X     Document Type: Article

References (29)

1. 1. Svec F, Nastasi K, Hilton C, Bao W, Srinivasan SR, Berenson GS. Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study. Diabetes 1992;41:313-7.
2. 2. Yanovski JA, Yanovski SZ, Filmer KM, Hubbard VS, Avila N, Lewis B, et al. Differences in body composition of black and white girls. Am J Clin Nutr 1996;64:833-9.
3. 3. Arslanian S, Suprasongsin C. Differences in the in vivo insulin secretion and sensitivity of healthy black versus white adolescents. J Pediatr 1996;129: 440-3.
4. 4. Juul A, Scheike T, Nielsen CT, Krabbe S, Muller J, Skakkebaek NE. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-relating hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). J Clin Endocrinol Metab 1995;80:3059-67.
5. 5. Baxter RC. Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatr Scand 1991; 372:107-14.
6. 6. Lee PDK, Conover CA, Powell DR. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 1993;204:4-29.
7. 7. Suwanickul A, Morris SL, Powell DR. Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1. J Biol Chem 1993; 268:17063-8.
8. 8. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994;79:872-8.
9. 9. Garn SM, Clark DC. Nutrition, growth, development, and maturation: findings from the Ten-State Nutrition Survey of 1968-1970. J Pediatr 1975; 56:306-19.
10. 10. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings Network. Pediatrics 1997;99:505-12.
11. 11. Garn SM, Clark DC, Trowbridge FL. Tendency toward greater stature in American black children. Am J Dis Child 1973;126:164-6.
12. 12. Owen GM, Lubin AH. Anthropometric differences between black and white preschool children. Am J Dis Child 1973;126:168-9.
13. 13. The National Heart, Lung, and Blood Institute Growth and Health Study Research Group. Obesity and cardiovascular disease risk factors in black and white girls: The NHLBI Growth and Health Study. Am J Public Health 1992;82:1613-20.
14. 14. Wong WW, Nicolson M, Stuff JE, Butte NF, Ellis KJ, Hergenroeder AC, et al. Serum leptin concentrations in Caucasian and African-American girls. J Clin Endocrinol Metab 1998;83:3574-7.
15. 15. Shypailo RJ, Posada JKJ, Ellis KJ. Whole-body phantoms with anthropomorphic-shaped skeletons for evaluation of dual-energy x-ray absorptiometry measurements. Appl Radiat Isot 1998;49:503-5.
16. 16. Tanner JM, Whitehouse RH. Variations of growth and development at puberty. In: Atlas of children's growth, normal variation and growth disorders. New York: Academic Press; 1982. p, 122-7.
17. 17. Hergenroeder AC, Hill RB, Wong WW, Sangi-Haghpeykar H, Taylor WC. Validity of self-assessment of pubertal maturation in African-American and European-American adolescents. J Adolesc Health 1999;24:201-5.
18. 18. Blum WT, Albertsson-Wikland K, Rosberg S, Ranke MB. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993;76:1610-6.
19. 19. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-42.
20. 20. Wilson DM, Killen JD, Hammer LD, Litt IF, Vosti C, Miner B, et al. Insulin-like growth factor-I as a reflection of body composition, nutrition, and puberty in sixth and seventh grade girls. J Clin Endocrinol Metab 1991;73:907-12.
21. 21. Olivie MAA, Garcia-Mayor RV, Leston DG, Sousa TR, Dominguez AS, Alvarez-Novoa R, et al. Serum insulin-like growth factor (IGF) binding protein-3 and IGF-I levels during childhood and adolescente. A cross-sectional study. Pediatr Res 1995;38:149-55.
22. 22. Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-I (IGF-I), IGF-binding protein-3, insulin, and growth hormone. Metabolism 1994;43:315-9.
23. 23. Copeland KC, Colletti RB, Devlin JT, McAuliffe TL. The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism 1990;39:584-7.
24. 1), and IGF-binding protein 1 and 2 (IGFBP 1 and 2) in lean and obese adolescents [abstract]. Obes Res 1997;5:5S.
25. 25. Conover CA, Lee PDK, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding-protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992;74:1355-60.
26. 26. Suikkari AM, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H. Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab 1989;68:135-40.
27. 27. Clemmons DR. Insulin-like growth factor binding proteins: roles in regulating IGF physiology. J Dev Physiol 1991;15:105-10.
28. 28. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H. Free insulin-like growth factors in human obesity. Metabolism 1995;44:37-44.
29. 29. Golay A, Felber J-P, Jequier E, De-Fronzo RA, Ferrannini E. Metabolic basis of obesity and noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 1988;4:727-47.